EBA
IGMS
Eagle Bay Advisors’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Hold |
99,635
| – | – | 0.09% | 109 |
|
|
2025
Q1 | $115K | Buy |
99,635
+55,000
| +123% | +$63.3K | 0.1% | 109 |
|
|
2024
Q4 | $273K | Hold |
44,635
| – | – | 0.17% | 89 |
|
|
2024
Q3 | $738K | Hold |
44,635
| – | – | 0.28% | 67 |
|
|
2024
Q2 | $307K | Hold |
44,635
| – | – | 0.19% | 82 |
|
|
2024
Q1 | $431K | Hold |
44,635
| – | – | 0.27% | 63 |
|
|
2023
Q4 | $371K | Hold |
44,635
| – | – | 0.23% | 75 |
|
|
2023
Q3 | $373K | Hold |
44,635
| – | – | 0.17% | 87 |
|
|
2023
Q2 | $412K | Buy |
44,635
+3,000
| +7% | +$27.7K | 0.24% | 66 |
|
|
2023
Q1 | $572K | Hold |
41,635
| – | – | 0.31% | 48 |
|
|
2022
Q4 | $708K | Hold |
41,635
| – | – | 0.4% | 45 |
|
|
2022
Q3 | $947K | Hold |
41,635
| – | – | 0.58% | 35 |
|
|
2022
Q2 | $751K | Buy |
41,635
+6,800
| +20% | +$123K | 0.45% | 40 |
|
|
2022
Q1 | $931K | Hold |
34,835
| – | – | 0.76% | 23 |
|
|
2021
Q4 | $1.02M | Sell |
34,835
-460
| -1% | -$13.5K | 0.65% | 22 |
|
|
2021
Q3 | $2.32M | Buy |
35,295
+460
| +1% | +$30.3K | 1.3% | 12 |
|
|
2021
Q2 | $2.9M | Buy |
+34,835
| New | +$2.9M | 2.33% | 8 |
|